HLHIX Holdings Information

HLHIX is a mutual fund with a total of 24 individual holdings. The top holdings are Eli Lilly and Company stock at 14.84%, West Pharmaceutical Services at 5.92%, AbbVie at 5.52%, Vertex Pharmaceuticals at 5.32%, and Merck & Co. at 5.06%.

Total Holdings

Top 10 Percentage

57.61%

Asset Class

Equity

Fund Category

Health

Assets

91.91M

Forward PE Ratio

n/a

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	14.84%	11,348
2	WST	West Pharmaceutical Services, Inc.	5.92%	15,110
3	ABBV	AbbVie Inc.	5.52%	20,131
4	VRTX	Vertex Pharmaceuticals Incorporated	5.32%	9,813
5	MRK	Merck & Co., Inc.	5.06%	36,134
6	UNH	UnitedHealth Group Incorporated	4.65%	10,264
7	MCK	McKesson Corporation	4.57%	5,542
8	MTD	Mettler-Toledo International Inc.	3.99%	2,865
9	ISRG	Intuitive Surgical, Inc.	3.89%	8,960
10	AMGN	Amgen Inc.	3.85%	9,757
11	COO	The Cooper Companies, Inc.	3.81%	48,681
12	IDXX	IDEXX Laboratories, Inc.	3.77%	6,572
13	TMO	Thermo Fisher Scientific Inc.	3.65%	6,684
14	LMRI	Lumexa Imaging Holdings, Inc.	3.60%	292,921
15	HQY	HealthEquity, Inc.	3.47%	35,255
16	DHR	Danaher Corporation	3.37%	16,221
17	DXCM	DexCom, Inc.	3.05%	41,497
18	REGN	Regeneron Pharmaceuticals, Inc.	2.90%	4,260
19	ALGN	Align Technology, Inc.	2.88%	15,674
20	STE	STERIS plc	2.32%	10,114
21	USPH	U.S. Physical Therapy, Inc.	2.30%	30,695
22	GMED	Globus Medical, Inc.	2.21%	25,630
23	MDLN	Medline Inc.	1.88%	43,666
24	PBH	Prestige Consumer Healthcare Inc.	1.65%	32,069

As of Jun 30, 2026